Why U.S. Mortality Rates Exceed Other Wealthy Nations

U.S.- OncoDaily

African Development Fund and WHO Join Forces To Rescue Sudan Health System

African Development Fund

5 FDA approved drugs for GI Cancers in the first of half 2025

GI cancers 5 FDA Drugs

Celebrating 50 Years of Advancing Pediatric Oncology Care in Italy - AIEOP

Pediatric Oncology

Nurse Practitioners Week 2025: Recognizing Compassionate Care and Dedication

Nurse Practitioners Week 2025

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Maria João Cardoso: Cinderella Project in ESMO AI 2025

Maria João Cardoso: Cinderella Project in ESMO AI 2025

Celebrating 25 Years of Pioneering Breast Cancer Research - The Institute of Cancer Research

Breast Cancer

OncoCalendar

« All Events

ESMO Targeted Anticancer Therapies Congress 2026

Mar 16, 2026 - Mar 18, 2026
ESMO TAT

The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development.

The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The event serves as a dynamic, multi-stakeholder meeting, uniting researchers, industry leaders, investors, and regulators to share new data, foster collaboration, and tackle the challenges of advancing early clinical development in oncology.

Elena Garralda, Carlos Gomez-Roca, and Cristian Massacesi serve as the co-chairs.

Details

Organizer

Venue